Single-genome sequencing of hepatitis C virus in donor-recipient pairs distinguishes modes and models of virus transmission and early diversification

Journal of Virology

Volumn 90, Issue 1, 2016, Pages 152-166

  Li, Hui ^a   Stoddard, Mark B ^a   Wang, Shuyi ^a   Giorgi, Elena E ^b   Blair, Lily M ^b,c   Learn, Gerald H ^a   Hahn, Beatrice H ^a   Alter, Harvey J ^d   Busch, Michael P ^e   Fierer, Daniel S ^f   Ribeiro, Ruy M ^b   Perelson, Alan S ^b   Bhattacharya, Tanmoy ^b,g   Shaw, George M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b LOS ALAMOS NATIONAL LABORATORY   (United States)

^c STANFORD UNIVERSITY   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g SANTA FE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ACUTE HEPATITIS C; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOTTLENECK POPULATION; CHIMPANZEE; CONTROLLED STUDY; DNA SEQUENCE; GENETIC VARIABILITY; GENOME ANALYSIS; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; MATHEMATICAL MODEL; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ALIGNMENT; UNINDEXED SEQUENCE; VIRUS GENOME; VIRUS REPLICATION; VIRUS TRANSMISSION; ADVERSE EFFECTS; ANIMAL; CLASSIFICATION; CLUSTER ANALYSIS; DONOR; GENETIC VARIATION; GENETICS; GENOTYPE; GENOTYPING TECHNIQUE; GRAFT RECIPIENT; HEPACIVIRUS; HEPATITIS C; ISOLATION AND PURIFICATION; LIVER TRANSPLANTATION; MOLECULAR GENETICS; PAN TROGLODYTES; SEQUENCE HOMOLOGY; THEORETICAL MODEL; TRANSMISSION; VETERINARY; VIROLOGY;

ANIMALS; CLUSTER ANALYSIS; GENETIC VARIATION; GENOME, VIRAL; GENOTYPE; GENOTYPING TECHNIQUES; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER TRANSPLANTATION; MODELS, THEORETICAL; MOLECULAR SEQUENCE DATA; PAN TROGLODYTES; PHYLOGENY; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; TISSUE DONORS; TRANSPLANT RECIPIENTS;

EID: 84952906204     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02156-15     Document Type: Article

References (77)

1. Ray SC, Thomas DL. 2010. Hepatitis C: principles and practice of infectious diseases, 7th ed. Churchill Livingstone/Elsevier Publishers, New York, NY.
2. AverhoffFM, Glass N, Holtzman D. 2012. Global burden of hepatitis C: considerations for healthcare providers in the United States. Clin Infect Dis 55(Suppl 1):S10-S15. http://dx.doi.org/10.1093/cid/cis361.
3. Law L, Landi A, Magee W, Tyrrell D, Houghton M. 2013. Progress toward a hepatitis C virus vaccine. Emerg Microbes Infect 2:e79. http://dx.doi.org/10.1038/emi.2013.79.
4. Liang TJ. 2013. Current progress in development of hepatitis C virus vaccines. Nat Med 19:869-878. http://dx.doi.org/10.1038/nm.3183.
5. Houghton M, Abrignani S. 2005. Prospects for a vaccine against the hepatitis C virus. Nature 436:961-966. http://dx.doi.org/10.1038/nature04081.
6. Farci P. 2011. New insights into the HCV quasispecies and compartmentalization. Semin Liver Dis 31:356-374. http://dx.doi.org/10.1055/s-0031-1297925.
7. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, Halfon P, Inchauspe G, Kuiken C, Maertens G, Mizokami M, Murphy DG, Okamoto H, Pawlotsky JM, Penin F, Sablon E, Shin IT, Stuyver LJ, Thiel HJ, Viazov S, Weiner AJ, Widell A. 2005. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42:962-973. http://dx.doi.org/10.1002/hep.20819.
8. Smith DB, Bukh J, Kuiken C, MuerhoffAS, Rice CM, Stapleton JT, Simmonds P. 2014. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology 59:318-327. http://dx.doi.org/10.1002/hep.26744.
9. Neumann AU, Lam NP, Dahari H, Gretch DR, Wiley TE, Layden TJ, Perelson AS. 1998. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 282:103-107. http://dx.doi.org/10.1126/science.282.5386.103.
10. Ribeiro RM, Li H, Wang S, Stoddard MB, Learn GH, Korber BT, Bhattacharya T, Guedj J, Parrish EH, Hahn BH, Shaw GM, Perelson AS. 2012. Quantifying the diversification of hepatitis C virus (HCV) during primary infection: estimates of the in vivo mutation rate. PLoS Pathog 8:e1002881. http://dx.doi.org/10.1371/journal.ppat.1002881.
11. Rong R. 2009. Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways. PLoS Pathog 5:e1000594. http://dx.doi.org/10.1371/journal.ppat.1000594.
12. Wang GP, Sherrill-Mix SA, Chang KM, Quince C, Bushman FD. 2010. Hepatitis C virus transmission bottlenecks analyzed by deep sequencing. J Virol 84:6218-6228. http://dx.doi.org/10.1128/JVI.02271-09.
13. Bull RA, Luciani F, McElroy K, Gaudieri S, Pham ST, Chopra A, Cameron B, Maher L, Dore GJ, White PA, Lloyd AR. 2011. Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection. PLoS Pathog 7:e1002243. http://dx.doi.org/10.1371/journal.ppat.1002243.
14. Li H, Stoddard MB, Wang S, Blair LM, Giorgi EE, Parrish EH, Learn GH, Hraber P, Goepfert PA, Saag MS, Denny TN, Haynes BF, Hahn BH, Ribeiro RM, Perelson AS, Korber BT, Bhattacharya T, Shaw GM. 2012. Elucidation of hepatitis C virus transmission and early diversification by single-genome sequencing. PLoS Pathog 8:e1002880. http://dx.doi.org/10.1371/journal.ppat.1002880.
15. Maheshwari A, Ray S, Thuluvath PJ. 2008. Acute hepatitis C Lancet 372:321-332.
16. Liang TJ, Ghany MG. 2013. Current and future therapies for hepatitis C virus infection. N Engl J Med 368:1907-1917. http://dx.doi.org/10.1056/NEJMra1213651.
17. Lauer GM. 2013. Immune responses to hepatitis C virus (HCV) infection and the prospects for an effective HCV vaccine or immunotherapies. J Infect Dis 207(Suppl 1):S7-S12. http://dx.doi.org/10.1093/infdis/jis762.
18. Busch MP, Shafer KA. 2005. Acute-phase hepatitis C virus infection: implications for research, diagnosis, and treatment. Clin Infect Dis 40: 959-961. http://dx.doi.org/10.1086/428583.
19. Page-Shafer K, Pappalardo BL, Tobler LH, Phelps BH, Edlin BR, Moss AR, Wright TL, Wright DJ, O'Brien TR, Caglioti S, Busch MP. 2008. Testing strategy to identify cases of acute hepatitisCvirus (HCV) infection and to project HCV incidence rates. J Clin Microbiol 46:499-506. http://dx.doi.org/10.1128/JCM.01229-07.
20. Suryaprasad AG, White JZ, Xu F, Eichler BA, Hamilton J, Patel A, Hamdounia SB, Church DR, Barton K, Fisher C, Macomber K, Stanley M, Guilfoyle SM, Sweet K, Liu S, Iqbal K, Tohme R, Sharapov U, Kupronis BA, Ward JW, Holmberg SD. 2014. Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012. Clin Infect Dis 59:1411-1419. http://dx.doi.org/10.1093/cid/ciu643.
21. van de Laar T, Pybus O, Bruisten S, Brown D, Nelson M, Bhagani S, Vogel M, Baumgarten A, Chaix ML, Fisher M, Gotz H, Matthews GV, Neifer S, White P, Rawlinson W, Pol S, Rockstroh J, Coutinho R, Dore GJ, Dusheiko GM, Danta M. 2009. Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men. Gastroenterology 136:1609-1617. http://dx.doi.org/10.1053/j.gastro.2009.02.006.
22. Zibbell J, Iqbal K, Patel R, Suryaprasad A, Sanders K, Moore-Moravian L, Serrecchia J, Blankenship S, Ward J, Holtzman D. 2015. Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years-Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012. MMWR Morb Mortal Wkly Rep 64:453-458.
23. Fierer D, Factor S, Uriel A, Carriero D, Dieterich D, Mullen M, Klepper A, van Seggelen W, Childs K, Branch A, Holtzman D, Ward J, Khudyakov Y, Holmberg S. 2011. Sexual transmission of hepatitis C virus among HIV-infected men who have sex with men-New York City, 2005-2010. MMWR Morb Mortal Wkly Rep 60:945-950.
24. Cox AL, Mosbruger T, Mao Q, Liu Z, Wang XH, Yang HC, Sidney J, Sette A, Pardoll D, Thomas DL, Ray SC. 2005. Cellular immune selection with hepatitis C virus persistence in humans. J Exp Med 201:1741-1752. http://dx.doi.org/10.1084/jem.20050121.
25. Farci P, Shimoda A, Coiana A, Diaz G, Peddis G, Melpolder JC, Strazzera A, Chien DY, Munoz SJ, Balestrieri A, Purcell RH, Alter HJ. 2000. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288:339-344. http://dx.doi.org/10.1126/science.288.5464.339.
26. Herring BL, Tsui R, Peddada L, Busch M, Delwart EL. 2005. Wide range of quasispecies diversity during primary hepatitis C virus infection. J Virol 79:4340-4346. http://dx.doi.org/10.1128/JVI.79.7.4340-4346.2005.
27. Kuntzen T, Timm J, Berical A, Lewis-Ximenez LL, Jones A, Nolan B, Schulze zur Wiesch J, Li B, Schneidewind A, Kim AY, Chung RT, Lauer GM, Allen TM. 2007. Viral sequence evolution in acute hepatitis C virus infection. J Virol 81:11658-11668. http://dx.doi.org/10.1128/JVI.00995-07.
28. Smith JA, Aberle JH, Fleming VM, Ferenci P, Thomson EC, Karayiannis P, McLean AR, Holzmann H, Klenerman P. 2010. Dynamic coinfection with multiple viral subtypes in acute hepatitis C. J Infect Dis 202: 1770-1779. http://dx.doi.org/10.1086/657317.
29. Tester I, Smyk-Pearson S, Wang P, Wertheimer A, Yao E, Lewinsohn DM, Tavis JE, Rosen HR. 2005. Immune evasion versus recovery after acute hepatitis C virus infection from a shared source. J Exp Med 201: 1725-1731. http://dx.doi.org/10.1084/jem.20042284.
30. Dowd KA, Netski DM, Wang XH, Cox AL, Ray SC. 2009. Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus. Gastroenterology 136:2377-2386. http://dx.doi.org/10.1053/j.gastro.2009.02.080.
31. Liu L, Fisher BE, Dowd KA, Astemborski J, Cox AL, Ray SC. 2010. Acceleration of hepatitis C virus envelope evolution in humans is consistent with progressive humoral immune selection during the transition from acute to chronic infection. J Virol 84:5067-5077. http://dx.doi.org/10.1128/JVI.02265-09.
32. Honegger JR, Kim S, Price AA, Kohout JA, McKnight KL, Prasad MR, Lemon SM, Grakoui A, Walker CM. 2013. Loss of immune escape mutations during persistent HCV infection in pregnancy enhances replication of vertically transmitted viruses. Nat Med 19:1529-1533. http://dx.doi.org/10.1038/nm.3351.
33. Stoddard MB, Li H, Wang S, Saeed M, Andrus L, Ding W, Jiang X, Learn GH, von Schaewen M, Wen J, Goepfert PA, Hahn BH, Ploss A, Rice CM, Shaw GM. 2015. Identification, molecular cloning, and analysis of full-length hepatitis C virus transmitted/founder genotypes 1, 3, and 4. mBio 6:e02518. http://dx.doi.org/10.1128/mBio.02518-14.
34. Brown RJ, Hudson N, Wilson G, Rehman SU, Jabbari S, Hu K, Tarr AW, Borrow P, Joyce M, Lewis J, Zhu LF, Law M, Kneteman N, Tyrrell DL, McKeating JA, Ball JK. 2012. Hepatitis C virus envelope glycoprotein fitness defines virus population composition following transmission to a new host. J Virol 86:11956-11966. http://dx.doi.org/10.1128/JVI.01079-12.
35. D'Arienzo V, Moreau A, D'Alteroche L, Gissot V, Blanchard E, Gaudy-Graffin C, Roch E, Dubois F, Giraudeau B, Plantier JC, Goudeau A, Roingeard P, Brand D. 2013. Sequence and functional analysis of the envelope glycoproteins of hepatitis C virus variants selectively transmitted to a new host. J Virol 87:13609-13618. http://dx.doi.org/10.1128/JVI.02119-13.
36. Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, Salazar MG, Sun C, Grayson T, Wang S, Li H, Wei X, Jiang C, Kirchherr JL, Gao F, Anderson JA, Ping LH, Swanstrom R, Tomaras GD, Blattner WA, Goepfert PA, Kilby JM, Saag MS, Delwart EL, Busch MP, Cohen MS, Montefiori DC, Haynes BF, Gaschen B, Athreya GS, Lee HY, Wood N, Seoighe C, Perelson AS, Bhattacharya T, Korber BT, Hahn BH, Shaw GM. 2008. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A 105:7552-7557. http://dx.doi.org/10.1073/pnas.0802203105.
37. Salazar-Gonzalez JF, Salazar MG, Keele BF, Learn GH, Giorgi EE, Li H, Decker JM, Wang S, Baalwa J, Kraus MH, Parrish NF, Shaw KS, Guffey MB, Bar KJ, Davis KL, Ochsenbauer-Jambor C, Kappes JC, Saag MS, Cohen MS, Mulenga J, Derdeyn CA, Allen S, Hunter E, Markowitz M, Hraber P, Perelson AS, Bhattacharya T, Haynes BF, Korber BT, Hahn BH, Shaw GM. 2009. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med 206:1273-1289. http://dx.doi.org/10.1084/jem.20090378.
38. Abrahams MR, Anderson JA, Giorgi EE, Seoighe C, Mlisana K, Ping LH, Athreya GS, Treurnicht FK, Keele BF, Wood N, Salazar-Gonzalez JF, Bhattacharya T, Chu H, Hoffman I, Galvin S, Mapanje C, Kazembe P, Thebus R, Fiscus S, Hide W, Cohen MS, Karim SA, Haynes BF, Shaw GM, Hahn BH, Korber BT, Swanstrom R, Williamson C. 2009. Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-Poisson distribution of transmitted variants. J Virol 83:3556-3567. http://dx.doi.org/10.1128/JVI.02132-08.
39. Haaland RE, Hawkins PA, Salazar-Gonzalez J, Johnson A, Tichacek A, Karita E, Manigart O, Mulenga J, Keele BF, Shaw GM, Hahn BH, Allen SA, Derdeyn CA, Hunter E. 2009. Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1. PLoS Pathog 5:e1000274. http://dx.doi.org/10.1371/journal.ppat.1000274.
40. Lee HY, Giorgi EE, Keele BF, Gaschen B, Athreya GS, Salazar-Gonzalez JF, Pham KT, Goepfert PA, Kilby JM, Saag MS, Delwart EL, Busch MP, Hahn BH, Shaw GM, Korber BT, Bhattacharya T, Perelson AS. 2009. Modeling sequence evolution in acute HIV-1 infection. J Theor Biol 261: 341-360. http://dx.doi.org/10.1016/j.jtbi.2009.07.038.
41. Giorgi EE, Funkhouser B, Athreya G, Perelson AS, Korber BT, Bhattacharya T. 2010. Estimating time since infection in early homogeneous HIV-1 samples using a Poisson model. BMC Bioinformatics 11:532. http://dx.doi.org/10.1186/1471-2105-11-532.
42. Drummond AJ, Ho SY, Phillips MJ, Rambaut A. 2006. Relaxed phylogenetics and dating with confidence. PLoS Biol 4:e88. http://dx.doi.org/10.1371/journal.pbio.0040088.
43. Drummond AJ, Rambaut A. 2007. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 7:214. http://dx.doi.org/10.1186/1471-2148-7-214.
44. Lindenbach BD, Thiel HJ, Rice C. 2007. Flaviviridae: the viruses and their replication, 5th ed, vol 1. Lippincott William & Wilkins, Philadelphia, PA.
45. Moradpour D, Penin F, Rice CM. 2007. Replication of hepatitis C virus. Nat Rev Microbiol 5:453-463. http://dx.doi.org/10.1038/nrmicro1645.
46. Quinkert D, Bartenschlager R, Lohmann V. 2005. Quantitative analysis of the hepatitis C virus replication complex. J Virol 79:13594-13605. http://dx.doi.org/10.1128/JVI.79.21.13594-13605.2005.
47. Brenner BG, Roger M, Routy JP, Moisi D, Ntemgwa M, Matte C, Baril JG, Thomas R, Rouleau D, Bruneau J, Leblanc R, Legault M, Tremblay C, Charest H, Wainberg MA, Quebec Primary HIVISG. 2007. High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis 195:951-959. http://dx.doi.org/10.1086/512088.
48. Pilcher CD, Eron JJ, Jr, Vemazza PL, Battegay M, Harr T, Yerly S, Vom S, Perrin L. 2001. Sexual transmission during the incubation period of primary HIV infection. JAMA 286:1713-1714. http://dx.doi.org/10.1001/jama.286.14.1713.
49. Ma ZM, Stone M, Piatak M, Jr, Schweighardt B, Haigwood NL, Montefiori D, Lifson JD, Busch MP, Miller CJ. 2009. High specific infectivity of plasma virus from the pre-ramp-up and ramp-up stages of acute simian immunodeficiency virus infection. J Virol 83:3288-3297. http://dx.doi.org/10.1128/JVI.02423-08.
50. Busch MP, Murthy KK, Kleinman SH, Hirschkorn DF, Herring BL, Delwart EL, Racanelli V, Yoon JC, Rehermann B, Alter HJ. 2012. Infectivity in chimpanzees (Pan troglodytes) of plasma collected before HCV RNA detectability by FDA-licensed assays: implications for transfusion safety andHCVinfection outcomes. Blood 119:6326-6334. http://dx.doi.org/10.1182/blood-2011-12-393637.
51. Guindon S, Gascuel O. 2003. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 52:696-704. http://dx.doi.org/10.1080/10635150390235520.
52. Cox AL, Netski DM, Mosbruger T, Sherman SG, Strathdee S, Ompad D, Vlahov D, Chien D, Shyamala V, Ray SC, Thomas DL. 2005. Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. Clin Infect Dis 40:951-958. http://dx.doi.org/10.1086/428578.
53. Rehermann B. 2009. Hepatitis C virus versus innate and adaptive im-mune responses: a tale of coevolution and coexistence. J Clin Invest 119: 1745-1754. http://dx.doi.org/10.1172/JCI39133.
54. Bowen DG, Walker CM. 2005. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 436:946-952. http://dx.doi.org/10.1038/nature04079.
55. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, Kidd J, Kidd K, Khakoo SI, Alexander G, Goedert JJ, Kirk GD, Donfield SM, Rosen HR, Tobler LH, Busch MP, McHutchison JG, Goldstein DB, Carrington M. 2009. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461:798-801. http://dx.doi.org/10.1038/nature08463.
56. Fischer W, Ganusov VV, Giorgi EE, Hraber PT, Keele BF, Leitner T, Han CS, Gleasner CD, Green L, Lo CC, Nag A, Wallstrom TC, Wang S, McMichael AJ, Haynes BF, Hahn BH, Perelson AS, Borrow P, Shaw GM, Bhattacharya T, Korber BT. 2010. Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing. PLoS One 5:e12303. http://dx.doi.org/10.1371/journal.pone.0012303.
57. Henn MR, Boutwell CL, Charlebois P, Lennon NJ, Power KA, Macalalad AR, Berlin AM, Malboeuf CM, Ryan EM, Gnerre S, Zody MC, Erlich RL, Green LM, Berical A, Wang Y, Casali M, Streeck H, Bloom AK, Dudek T, Tully D, Newman R, Axten KL, Gladden AD, Battis L, Kemper M, Zeng Q, Shea TP, Gujja S, Zedlack C, Gasser O, Brander C, Hess C, Gunthard HF, Brumme ZL, Brumme CJ, Bazner S, Rychert J, Tinsley JP, Mayer KH, Rosenberg E, Pereyra F, Levin JZ, Young SK, Jessen H, Altfeld M, Birren BW, Walker BD, Allen TM. 2012. Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection. PLoS Pathog 8:e1002529. http://dx.doi.org/10.1371/journal.ppat.1002529.
58. Burke KP, Munshaw S, Osburn WO, Levine J, Liu L, Sidney J, Sette A, Ray SC, Cox AL. 2012. Immunogenicity and cross-reactivity of a representative ancestral sequence in hepatitis C virus infection. J Immunol 188:5177-5188. http://dx.doi.org/10.4049/jimmunol.1103008.
59. Kong L, Giang E, Nieusma T, Kadam RU, Cogburn KE, Hua Y, Dai X, Stanfield RL, Burton DR, Ward AB, Wilson IA, Law M. 2013. Hepatitis C virus E2 envelope glycoprotein core structure. Science 342:1090-1094. http://dx.doi.org/10.1126/science.1243876.
60. Yerly D, Heckerman D, Allen T, Suscovich TJ, Jojic N, Kadie C, Pichler WJ, Cerny A, Brander C. 2008. Design, expression, and processing of epitomized hepatitis C virus-encoded CTL epitopes. J Immunol 181: 6361-6370. http://dx.doi.org/10.4049/jimmunol.181.9.6361.
61. Bull RA, Leung P, Gaudieri S, Deshpande P, Cameron B, Walker M, Chopra A, Lloyd AR, Luciani F. 2015. Transmitted/founder viruses rapidly escape from CD8+ T cell responses in acute hepatitis C virus infection. J Virol 89:5478-5490. http://dx.doi.org/10.1128/JVI.03717-14.
62. Li H, Bar KJ, Wang S, Decker JM, Chen Y, Sun C, Salazar-Gonzalez JF, Salazar MG, Learn GH, Morgan CJ, Schumacher JE, Hraber P, Giorgi EE, Bhattacharya T, Korber BT, Perelson AS, Eron JJ, Cohen MS, Hicks CB, Haynes BF, Markowitz M, Keele BF, Hahn BH, Shaw GM. 2010. High multiplicity infection by HIV-1 in men who have sex with men. PLoS Pathog 6:e1000890. http://dx.doi.org/10.1371/journal.ppat.1000890.
63. Bar KJ, Li H, Chamberland A, Tremblay C, Routy JP, Grayson T, Sun C, Wang S, Learn GH, Morgan CJ, Schumacher JE, Haynes BF, Keele BF, Hahn BH, Shaw GM. 2010. Wide variation in the multiplicity of HIV-1 infection among injection drug users. J Virol 84:6241-6247. http://dx.doi.org/10.1128/JVI.00077-10.
64. Irving WL, Brown RJ. 2010. Acute hepatitis C virus infection: a dynamicand challenging-concept. J Infect Dis 202:1765-1767. http://dx.doi.org/10.1086/657318.
65. Edlefsen PT, Rolland M, Hertz T, Tovanabutra S, Gartland AJ, deCamp AC, Magaret CA, Ahmed H, Gottardo R, Juraska M, McCoy C, Larsen BB, Sanders-Buell E, Carrico C, Menis S, Bose M, Team RVS, Arroyo MA, O'Connell RJ, Nitayaphan S, Pitisuttithum P, Kaewkungwal J, Rerks-Ngarm S, Robb ML, Kirys T, Georgiev IS, Kwong PD, Scheffler K, Pond SL, Carlson JM, Michael NL, Schief WR, Mullins JI, Kim JH, Gilbert PB. 2015. Comprehensive sieve analysis of breakthrough HIV-1 sequences in the RV144 vaccine efficacy trial. PLoS Comput Biol 11: e1003973. http://dx.doi.org/10.1371/journal.pcbi.1003973.
66. Edlefsen PT, Gilbert PB, Rolland M. 2013. Sieve analysis in HIV-1 vaccine efficacy trials. Curr Opin HIV AIDS 8:432-436.
67. Rolland M, Tovanabutra S, deCamp AC, Frahm N, Gilbert PB, Sanders-Buell E, Heath L, Magaret CA, Bose M, Bradfield A, O'Sullivan A, Crossler J, Jones T, Nau M, Wong K, Zhao H, Raugi DN, Sorensen S, Stoddard JN, Maust BS, Deng W, Hural J, Dubey S, Michael NL, Shiver J, Corey L, Li F, Self SG, Kim J, Buchbinder S, Casimiro DR, Robertson MN, Duerr A, McElrath MJ, McCutchan FE, Mullins JI. 2011. Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial. Nat Med 17:366-371. http://dx.doi.org/10.1038/nm.2316.
68. Rolland M, Edlefsen PT, Larsen BB, Tovanabutra S, Sanders-Buell E, Hertz T, deCamp AC, Carrico C, Menis S, Magaret CA, Ahmed H, Juraska M, Chen L, Konopa P, Nariya S, Stoddard JN, Wong K, Zhao H, Deng W, Maust BS, Bose M, Howell S, Bates A, Lazzaro M, O'Sullivan A, Lei E, Bradfield A, Ibitamuno G, Assawadarachai V, O'Connell RJ, deSouza MS, Nitayaphan S, Rerks-Ngarm S, Robb ML, McLellan JS, Georgiev I, Kwong PD, Carlson JM, Michael NL, Schief WR, Gilbert PB, Mullins JI, Kim JH. 2012. Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2. Nature 490:417-420. http://dx.doi.org/10.1038/nature11519.
69. Colloca S, Barnes E, Folgori A, Ammendola V, Capone S, Cirillo A, Siani L, Naddeo M, Grazioli F, Esposito ML, Ambrosio M, Sparacino A, Bartiromo M, Meola A, Smith K, Kurioka A, O'Hara GA, Ewer KJ, Anagnostou N, Bliss C, Hill AV, Traboni C, Klenerman P, Cortese R, Nicosia A. 2012. Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species. Sci Transl Med 4:115ra112.
70. Goonetilleke N, Liu MK, Salazar-Gonzalez JF, Ferrari G, Giorgi E, Ganusov VV, Keele BF, Learn GH, Turnbull EL, Salazar MG, Weinhold KJ, Moore S, Letvin N, Haynes BF, Cohen MS, Hraber P, Bhattacharya T, Borrow P, Perelson AS, Hahn BH, Shaw GM, Korber BT, McMichael AJ. 2009. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med 206: 1253-1272. http://dx.doi.org/10.1084/jem.20090365.
71. Sanjuan R, Nebot MR, Chirico N, Mansky LM, Belshaw R. 2010. Viral mutation rates. J Virol 84:9733-9748. http://dx.doi.org/10.1128/JVI.00694-10.
72. Guedj J, Dahari H, Rong L, Sansone ND, Nettles RE, Cotler SJ, Layden TJ, Uprichard SL, Perelson AS. 2013. Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life. Proc Natl Acad Sci U S A 110:3991-3996. http://dx.doi.org/10.1073/pnas.1203110110.
73. Palmer S, Kearney M, Maldarelli F, Halvas EK, Bixby CJ, Bazmi H, Rock D, Falloon J, Davey RT, Jr, Dewar RL, Metcalf JA, Hammer S, Mellors JW, Coffin JM. 2005. Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis. J Clin Microbiol 43:406-413. http://dx.doi.org/10.1128/JCM.43.1.406-413.2005.
74. Liu MK, Hawkins N, Ritchie AJ, Ganusov VV, Whale V, Brackenridge S, Li H, Pavlicek JW, Cai F, Rose-Abrahams M, Treurnicht F, Hraber P, Riou C, Gray C, Ferrari G, Tanner R, Ping LH, Anderson JA, Swanstrom R, Cohen M, Karim SS, Haynes B, Borrow P, Perelson AS, Shaw GM, Hahn BH, Williamson C, Korber BT, Gao F, Self S, McMichael A, Goonetilleke N. 2013. Vertical T cell immunodominance and epitope entropy determine HIV-1 escape. J Clin Invest 123:380-393.
75. Bar KJ, Tsao CY, Iyer SS, Decker JM, Yang Y, Bonsignori M, Chen X, Hwang KK, Montefiori DC, Liao HX, Hraber P, Fischer W, Li H, Wang S, Sterrett S, Keele BF, Ganusov VV, Perelson AS, Korber BT, Georgiev I, McLellan JS, Pavlicek JW, Gao F, Haynes BF, Hahn BH, Kwong PD, Shaw GM. 2012. Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escape. PLoS Pathog 8:e1002721. http://dx.doi.org/10.1371/journal.ppat.1002721.
76. Liao HX, Lynch R, Zhou T, Gao F, Alam SM, Boyd SD, Fire AZ, Roskin KM, Schramm CA, Zhang Z, Zhu J, Shapiro L, Program NCS, Mullikin JC, Gnanakaran S, Hraber P, Wiehe K, Kelsoe G, Yang G, Xia SM, Montefiori DC, Parks R, Lloyd KE, Scearce RM, Soderberg KA, Cohen M, Kamanga G, Louder MK, Tran LM, Chen Y, Cai F, Chen S, Moquin S, Du X, Joyce MG, Srivatsan S, Zhang B, Zheng A, Shaw GM, Hahn BH, Kepler TB, Korber BT, Kwong PD, Mascola JR, Haynes BF. 2013. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature 496:469-476. http://dx.doi.org/10.1038/nature12053.
77. Roederer M, Keele BF, Schmidt SD, Mason RD, Welles HC, Fischer W, Labranche C, Foulds KE, Louder MK, Yang ZY, Todd JP, Buzby AP, Mach LV, Shen L, Seaton KE, Ward BM, Bailer RT, Gottardo R, Gu W, Ferrari G, Alam SM, Denny TN, Montefiori DC, Tomaras GD, Korber BT, Nason MC, Seder RA, Koup RA, Letvin NL, Rao SS, Nabel GJ, Mascola JR. 2014. Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV. Nature 505:502-508.